GFAP and androgen insensitivity syndrome: For the analysis of GFAP, 11 studies were eligible for inclusion comprising 1,152 AIS patients and 617 control patients (HC: n = 342, stroke mimics: n = 275) (15, 16, 57, 80–85) (Table 4).